drugset / Trial / NCT04347382

Honey & Nigella Sativa Trial Against COVID-19

NCT04347382

Phase 3 Completed 313 enrolled Sohaib Ashraf
RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate the effectiveness of Nigella Sativa and honey stirred in 250 ml of distilled water 12 hourly till patient becomes asymptomatic or a maximum of 14 days with standard hospital care versus standard hospital care alone with placebo capsule and 250 ml water, in clearing the COVID-19 nucleic acid from throat and nasal swab, lowering disease detrimental effects on HRCT chest/X-ray and severity of symptoms along with duration of hospital stay till day 14th day of follow up and 30 days mortality (primary outcomes).

Timeline

Start
2020-04-30
Primary completion
2020-08-30
Completion
2020-08-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Honey Unknown 1 g/kg Oral
Subject Nigella sativa Traditional medicine (herbal / TCM) 80 mg/kg

Indications